907 related articles for article (PubMed ID: 8181146)
1. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
2. Role of tissue angiotensin II in myocardial remodelling induced by mechanical stress.
Yamazaki T; Yazaki Y
J Hum Hypertens; 1999 Jan; 13 Suppl 1():S43-7; discussion S49-50. PubMed ID: 10076920
[TBL] [Abstract][Full Text] [Related]
3. Role of the renin-angiotensin system in cardiac hypertrophy.
Yamazaki T; Komuro I; Yazaki Y
Am J Cardiol; 1999 Jun; 83(12A):53H-57H. PubMed ID: 10750588
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction.
Yamazaki T; Shiojima I; Komuro I; Nagai R; Yazaki Y
J Hypertens Suppl; 1994 Nov; 12(9):S23-7. PubMed ID: 7884580
[TBL] [Abstract][Full Text] [Related]
5. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
Mizuno K; Niimura S; Katoh K; Fukuchi S
Life Sci; 1994; 54(25):1987-94. PubMed ID: 8201847
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
[TBL] [Abstract][Full Text] [Related]
7. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Paull JR; Widdop RE
J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
Brilla CG; Scheer C; Rupp H
J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
[TBL] [Abstract][Full Text] [Related]
9. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
[TBL] [Abstract][Full Text] [Related]
10. Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
Mori T; Nishimura H; Ueyama M; Kubota J; Kawamura K
Jpn Circ J; 1995 Sep; 59(9):624-30. PubMed ID: 7500546
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of three sites of renin-angiotensin blockade on the regression of left ventricular hypertrophy in spontaneously hypertensive rats.
Zhang Q; Kohara K; Qui HY; Hiwada K
Am J Ther; 1997; 4(5-6):199-202. PubMed ID: 10423611
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
Kagoshima T; Masuda J; Sutani T; Sakaguchi Y; Tsuchihashi M; Tsuruta S; Iwano M; Dohi K; Nakamura Y; Konishi N
Blood Press Suppl; 1994; 5():89-93. PubMed ID: 7889210
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction.
Yamazaki T; Shiojima I; Komuro I; Nagai R; Yazaki Y
J Hypertens Suppl; 1994 Dec; 12(10):S153-7. PubMed ID: 7769485
[TBL] [Abstract][Full Text] [Related]
14. Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats.
Hara K; Kobayashi N; Nakano S; Mori Y; Tsubokou Y; Matsuoka H
Hypertens Res; 2001 Jan; 24(1):55-64. PubMed ID: 11213031
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
Kawano H; Cody RJ; Graf K; Goetze S; Kawano Y; Schnee J; Law RE; Hsueh WA
Hypertension; 2000 Jan; 35(1 Pt 2):273-9. PubMed ID: 10642310
[TBL] [Abstract][Full Text] [Related]
16. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
Dahlöf B
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
[TBL] [Abstract][Full Text] [Related]
17. Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias. Beneficial effect of angiotensin II blockade.
Kohya T; Yokoshiki H; Tohse N; Kanno M; Nakaya H; Saito H; Kitabatake A
Circ Res; 1995 May; 76(5):892-9. PubMed ID: 7729007
[TBL] [Abstract][Full Text] [Related]
18. The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats.
Yu H; Rakugi H; Higaki J; Morishita R; Mikami H; Ogihara T
J Hypertens; 1993 Dec; 11(12):1347-55. PubMed ID: 8133017
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
[TBL] [Abstract][Full Text] [Related]
20. TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats.
Kobayashi N; Mori Y; Nakano S; Tsubokou Y; Kobayashi T; Shirataki H; Matsuoka H
Atherosclerosis; 2001 Oct; 158(2):359-68. PubMed ID: 11583714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]